GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sequent Scientific Ltd (BOM:512529) » Definitions » EV-to-FCF

Sequent Scientific (BOM:512529) EV-to-FCF : (As of Apr. 12, 2025)


View and export this data going back to 1991. Start your Free Trial

What is Sequent Scientific EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Sequent Scientific's Enterprise Value is ₹38,958 Mil. Sequent Scientific's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was ₹0 Mil. Therefore, Sequent Scientific's EV-to-FCF for today is .

The historical rank and industry rank for Sequent Scientific's EV-to-FCF or its related term are showing as below:

BOM:512529' s EV-to-FCF Range Over the Past 10 Years
Min: -17828.31   Med: 0   Max: 0
Current: -17828.31

BOM:512529's EV-to-FCF is ranked worse than
100% of 548 companies
in the Drug Manufacturers industry
Industry Median: 22.62 vs BOM:512529: -17828.31

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-04-12), Sequent Scientific's stock price is ₹136.85. Sequent Scientific's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was ₹0.460. Therefore, Sequent Scientific's PE Ratio (TTM) for today is 297.50.


Sequent Scientific EV-to-FCF Historical Data

The historical data trend for Sequent Scientific's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sequent Scientific EV-to-FCF Chart

Sequent Scientific Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 30.43 100.92 -1,974.96 -32.62 -15,785.47

Sequent Scientific Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -15,785.47 - - -

Competitive Comparison of Sequent Scientific's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Sequent Scientific's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sequent Scientific's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sequent Scientific's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Sequent Scientific's EV-to-FCF falls into.


;
;

Sequent Scientific EV-to-FCF Calculation

Sequent Scientific's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=38958.012/0
=

Sequent Scientific's current Enterprise Value is ₹38,958 Mil.
Sequent Scientific's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sequent Scientific  (BOM:512529) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Sequent Scientific's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=136.85/0.460
=297.50

Sequent Scientific's share price for today is ₹136.85.
Sequent Scientific's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.460.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Sequent Scientific EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Sequent Scientific's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Sequent Scientific Business Description

Traded in Other Exchanges
Address
Plot No. E7, Road No. 22, 301, 3rd Floor, Dosti Pinnacle, Wagle Industrial Estate, Thane (West), Mumbai, MH, IND, 400 604
Sequent Scientific Ltd is a pharmaceutical company operating animal health and analytical services. It develops API products and formulations. The company's product portfolio includes products across various therapy classes such as antibiotics, anthelmintics, pain management, and nutrition. The company's geographical segment includes Europe, Asia, and Rest of the world. It generates maximum revenue from Europe.

Sequent Scientific Headlines

No Headlines